Use of bradycardiac substances in the treatment of myocardial diseases associated with hypertrophy and novel medicament combinations
Details for Australian Patent Application No. 2001270484 (hide)
International Classifications
Event Publications
13 May 2004 Change of Name(s) of Applicant(s), Section 104
Boehringer Ingelheim Pharma KG The name of the applicant has been changed to Boehringer Ingelheim Pharma GmbH & Co. KG 2002
25 January 2007 Application Accepted
Published as AU-B-2001270484
24 May 2007 Standard Patent Sealed
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser